Instrument for nucleic acid analysis - ANVISA Registration 10322250133

Access comprehensive regulatory information for Instrument for nucleic acid analysis in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322250133 and manufactured by QIAGEN GMBH. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE MOLECULAR SYSTEMS, INC, LIFE TECHNOLOGIES HOLDINGS PTE LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.